Capital Group Private Client Services’s Genmab GMAB Stock Holding History

Capital Group Private Client Services’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-39,931	Closed	-$974K	–	275
2024 Q3	$974K	Hold	39,931	–	–	0.01%	224
2024 Q2	$1M	Sell	39,931 -25	-0.1%	-$709	0.01%	225
2024 Q1	$1.2M	Buy	39,956 +11,359	+40%	+$334K	0.01%	222
2023 Q4	$911K	Hold	28,597	–	–	0.01%	220
2023 Q3	$1.01M	Hold	28,597	–	–	0.01%	206
2023 Q2	$1.09M	Hold	28,597	–	–	0.01%	197
2023 Q1	$1.08M	Hold	28,597	–	–	0.01%	198
2022 Q4	$1.21M	Hold	28,597	–	–	0.02%	188
2022 Q3	$919K	Sell	28,597 -7,624	-21%	-$268K	0.01%	193
2022 Q2	$1.18M	Buy	+36,221	New	+$1.17M	0.02%	190

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Capital Group Private Client Services's GMAB Position: Q4 2024 in Review

Capital Group Private Client Services sold out of Genmab (GMAB) in Q4 2024, closing a stake of 39,931 shares — an estimated $974K sold.

Capital Group Private Client Services first reported a position in GMAB in Q2 2022 and held it in 10 quarters. The position peaked at $1.21M in Q4 2022. 228 funds tracked by Wall St. Rank hold GMAB as of Q4 2024.

Capital Group Private Client Services reported no remaining Genmab position as of Q4 2024 after selling out during the quarter.
Capital Group Private Client Services sold 39,931 Genmab shares in Q4 2024, an estimated $974K.
Capital Group Private Client Services first reported a position in Genmab in Q2 2022 and held it in 10 quarters.
Capital Group Private Client Services's Genmab position peaked at $1.21M in Q4 2022.
228 funds tracked by Wall St. Rank held Genmab as of Q4 2024.

Based on Capital Group Private Client Services's 13F filing for Q4 2024, filed 13 Feb 2025.